140 related articles for article (PubMed ID: 36505290)
21. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma.
Chen H; Nio K; Yamashita T; Okada H; Li R; Suda T; Li Y; Doan PTB; Seki A; Nakagawa H; Toyama T; Terashima T; Iida N; Shimakami T; Takatori H; Kawaguchi K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Mol Oncol; 2021 Aug; 15(8):2203-2218. PubMed ID: 33834612
[TBL] [Abstract][Full Text] [Related]
22. Autophagy inhibition enhances Matrine derivative MASM induced apoptosis in cancer cells via a mechanism involving reactive oxygen species-mediated PI3K/Akt/mTOR and Erk/p38 signaling.
Zou Y; Sarem M; Xiang S; Hu H; Xu W; Shastri VP
BMC Cancer; 2019 Oct; 19(1):949. PubMed ID: 31615459
[TBL] [Abstract][Full Text] [Related]
23. Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness.
Lai HC; Chung WM; Chang CM; Liao PY; Su YT; Yeh CC; Jeng LB; Ma WL; Chang WC
Anticancer Res; 2020 Mar; 40(3):1285-1295. PubMed ID: 32132025
[TBL] [Abstract][Full Text] [Related]
24. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
25. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway.
Wei X; You X; Zhang J; Zhou C
Mol Ther Nucleic Acids; 2019 Jun; 16():721-732. PubMed ID: 31128423
[TBL] [Abstract][Full Text] [Related]
27. DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer.
Wang Q; Liang N; Yang T; Li Y; Li J; Huang Q; Wu C; Sun L; Zhou X; Cheng X; Zhao L; Wang G; Chen Z; He X; Liu C
J Hepatol; 2021 Nov; 75(5):1142-1153. PubMed ID: 34217777
[TBL] [Abstract][Full Text] [Related]
28. IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells.
Li Y; Chen G; Han Z; Cheng H; Qiao L; Li Y
Onco Targets Ther; 2020; 13():9721-9730. PubMed ID: 33061451
[TBL] [Abstract][Full Text] [Related]
29. Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM
Takai A; Dang H; Oishi N; Khatib S; Martin SP; Dominguez DA; Luo J; Bagni R; Wu X; Powell K; Ye QH; Jia HL; Qin LX; Chen J; Mitchell GA; Luo X; Thorgeirsson SS; Wang XW
Cancer Res; 2019 May; 79(9):2379-2391. PubMed ID: 30862714
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
[TBL] [Abstract][Full Text] [Related]
31. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
[TBL] [Abstract][Full Text] [Related]
32. 6-C-(E-Phenylethenyl)Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling.
Kang Q; Gong J; Wang M; Wang Q; Chen F; Cheng KW
J Agric Food Chem; 2019 Dec; 67(50):13939-13947. PubMed ID: 31769973
[TBL] [Abstract][Full Text] [Related]
33. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
[TBL] [Abstract][Full Text] [Related]
34. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
35. Connexin32 regulates expansion of liver cancer stem cells via the PI3K/Akt signaling pathway.
Li H; Wang B; Qi B; Jiang G; Qin M; Yu M
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35894130
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways.
Chen W; You J; Zheng Q; Zhu YY
Cancer Manag Res; 2018; 10():1817-1826. PubMed ID: 29997441
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of liver developmental microRNA contribute to hepatic carcinogenesis.
Wu JF; Ho MC; Ni YH; Hsu HY; Lee PH; Chang MH
J Formos Med Assoc; 2020 Jun; 119(6):1041-1051. PubMed ID: 31627983
[TBL] [Abstract][Full Text] [Related]
38. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
[TBL] [Abstract][Full Text] [Related]
39. The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In Vitro.
Kim YJ; Yuk N; Shin HJ; Jung HJ
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639072
[TBL] [Abstract][Full Text] [Related]
40. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]